skeleton possess antimicrobial activity, viz., anti-TB and antibacterial activity. [3] This endless requirement resulted in further work on pyrazine-2-carbohydrazide. In the present study, pyrazinamide was hydrolyzed and esteriÞ ed to get obtain ethyl-pyrazinoate and was reacted with hydrazine hydrate to yield pyrazinoic acid hydrazide. This pyrazinoic acid hydrazide was then condensed with various substituted aromatic aldehydes to yield different pyrazine carbohydrazide derivatives so as to increase log P value, and thereby to increase the intracellular concentration in order to decrease the resistance developed due to decreased intracellular concentration of the drug. These synthesized compounds were subjected to preliminary biological evaluation (Scheme 1).
INTRODUCTION
The incidence of microbial infections is increasing worldwide despite active research devoted to the discovery and development of novel antimicrobial agents. Emergence of multiresistant strains of bacteria has increased the problem of drug resistance dramatically. Furthermore, treatment of infectious diseases is more difficult in immunocompromised patients such as those infected with human immunodeÞ ciency virus (HIV). Various novel approaches were carried out to the current existing drugs for reducing the microbial resistance. These mainly involve structural modiÞ cation of existing antimicrobial agents so as to increase microbial intracellular concentration of drug, and thereby to increase antimicrobial activity. The thorough literature survey reveals that the parent molecules having hydrazide and hydrazones groups in their structure is shown potent antimicrobial activity. [1, 2] The literature survey reveals that the molecules having hydrazide spots were rendered visible by exposing to UV light and iodine fumes. Column chromatographic separations were carried out by gradient elution with methanol/ethanol-ethyl acetate mixture and silica gel (60-120/100-200 mesh). The compounds were puriÞ ed by recrystallization using aqueous ethanol as a solvent. HPLC was performed on JASCO 2000 SERIES instrument using C-18 reverse-phase column and diodearray UV detector.
Melting points were determined in open capillaries using Veego VMP-1 electrothermal melting point apparatus and were uncorrected. The absorbance (λ max ) was taken on JASCO 630V spectrophotometer using methanol as solvent. The infrared (IR) spectra were recorded on JASCO FTIR 4100 Series spectrometer in KBr pellets and the frequencies recorded in wave numbers. 1 H NMR spectra were recorded on "VARIAN MERCURY YH-300" spectrophotometer at 300 MHz in DMSO-d6/ CDCl 3 solutions and their chemical shifts are recorded in δ (parts per million) units with respect to tetramethyl silane (TMS) as an internal standard. The mass spectra were recorded on Waters Q-ToF micro on electron spray ionization (ESI) source. Elemental analyses observed for all the newly synthesized compounds were found to be within the limits of accuracy.
Procedure for synthesis of pyrazinoic acid hydrazide [I]
Pyrazinamide (0.1 mol) was hydrolyzed to obtain pyrazinoic acid by alkaline hydrolysis. The acid obtained was dissolved in ethanol and few drops of conc. H 2 SO 4 was added and reß uxed for 24 h; hydrazine hydrate 100% (3.0 mol) was added to it and further reß uxed for a period of 8 h. The excess of solvent was distilled off to obtain the resulting product. The product was crystallized from aqueous ethanol. [4, 5] Procedure for synthesis of pyrazine-2-carbohydrazide [PH 1-14] (General Procedure)
A solution of aromatic/substituted aldehyde (0.05 mol) in ethanol was added to a solution of so obtained pyrazinoic acid hydrazide (0.05 mol) in 10 ml ethanol. The mixture was reß uxed for 4 h. After cooling the mixture, the precipitate was Þ ltered, dried and recrystallized from aqueous ethanol. [6, 7] Synthesis and Characterization of Pyrazine-2-Carbohydrazide Derivatives as Anti-microbial Agents the National Collection of Industrial Microorganism (NCIM)-NCL, Pune. The in vitro antibacterial activity of the compounds PH 1-14 were carried out by the agar cup plate method. [8, 9] The concentration of compound (250 µg/ml) were prepared in dimethyl sulfoxide (DMSO). Oß oxacin was used as standard.
The antibacterial activity was evaluated by using 24-h cultures of S. aureus, B. subtilis, Salmonella typhi and E. coli using Muller Hinton agar medium. The medium was sterilized by autoclaving at 120°C (15 lb/in 2 ) for 30 min. About 30 ml of molten nutrient agar medium inoculated with the respective strains of bacteria (6 ml of inoculum to 300 ml of nutrient agar medium) was transferred aseptically into each sterilized petridishes (10 cm diameter). The plates were left at room temperature to allow solidiÞ cation of the media. In each plate, 3 wells of 6 mm diameter were made using a sterile borer. Accurately 0.1 ml of the test and standard solution were transferred to the wells aseptically by micropipette and labeled accordingly. The plates were then maintained at room temperature for 2 h to allow the diffusion of the solution in the medium. The petridishes used for antibacterial screening were incubated at 37±1°C for 24 h. The diameter of zone of inhibition surrounding each well was recorded.
The compounds exhibited antibacterial activity against S. aureus, B. subtilis, Salmonella typhi and E. coli, which were assayed on a quantitative basis determining the Minimal Inhibitory Concentration (MIC) for that microorganisms.
RESULTS AND DISCUSSION
In series 1, seven compounds showed antibacterial activity against S. aureus and B. subtilis. The derivatives PH01, PH02, PH03, PH04, PH08, PH09 and PH10 have been found to be active among the compounds tested, whereas in the same series only three and two compounds showed antibacterial activity against E. coli and Salmonella typhi, respectively [ Table 1 ]. The compounds PH05, PH06 and PH 07 were found to be active against E. coli and compound PH12 and PH 14 were found to be active against Salmonella typhi as compared with the standard oß oxacin [ Table 2 ].
CONCLUSION
From the IR, 1 HNMR and MS spectral data, the assigned structure were established. The synthesized compounds showed potent antimicrobial activity against the selected strains of Gram-positive bacteria as compared to Gramnegative bacteria. All the compounds in Table 1 were crystallized from aq. ethanol. Purity of the compounds in Table 1 -PH 2  200  180  --PH 3  190  190  --PH 4  210  200  --PH 5  --190  -PH 6  --200  -PH 7  --210  -PH 8  180  180  --PH 9  190  200  --PH 10  190  190  --PH 11  ----PH 12  ---230  PH 13  ----PH 14  ---200 Results are expressed in microgram per milliliter concentration Table 3 shows the MIC values of active antibacterial compounds in the range 180-230 µg/ml concentrations against common bacterial infection causing species. This indicates that the synthesized compounds were active against routinely infection causing bacteria. Further molecular manipulations of the lead molecule may improve the spectrum of antimicrobial activity. Hence, further studies are going in this direction in our laboratory by using modern sophisticated tools of drug design, viz., QSAR and molecular modeling to obtain new broad-spectrum antimicrobial agents.
